245 related articles for article (PubMed ID: 22226967)
21. Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D
Lundqvist J; Kirkegaard T; Laenkholm AV; Duun-Henriksen AK; Bak M; Feldman D; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2018 Mar; 177():171-178. PubMed ID: 28610873
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.
Zhang X; Mukerji R; Samadi AK; Cohen MS
BMC Complement Altern Med; 2011 Oct; 11():84. PubMed ID: 21978374
[TBL] [Abstract][Full Text] [Related]
23. Estrogenic compound attenuates angiotensin II-induced vascular smooth muscle cell proliferation through interaction between LKB1 and estrogen receptor α.
Kim SA; Lee KY; Kim JR; Choi HC
J Pharmacol Sci; 2016 Sep; 132(1):78-85. PubMed ID: 27665370
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
[TBL] [Abstract][Full Text] [Related]
25. The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells.
Adams BD; Cowee DM; White BA
Mol Endocrinol; 2009 Aug; 23(8):1215-30. PubMed ID: 19423651
[TBL] [Abstract][Full Text] [Related]
26. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.
Imai Y; Ishikawa E; Asada S; Sugimoto Y
Cancer Res; 2005 Jan; 65(2):596-604. PubMed ID: 15695404
[TBL] [Abstract][Full Text] [Related]
27. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.
Ellison-Zelski SJ; Alarid ET
Mol Cancer; 2010 Sep; 9():263. PubMed ID: 20920219
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
[TBL] [Abstract][Full Text] [Related]
29. Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer.
Tokuda E; Seino Y; Arakawa A; Saito M; Kasumi F; Hayashi S; Yamaguchi Y
Breast Cancer Res Treat; 2012 Jun; 133(2):427-36. PubMed ID: 21909982
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashion.
JavanMoghadam S; Weihua Z; Hunt KK; Keyomarsi K
Cell Cycle; 2016 Jun; 15(12):1579-90. PubMed ID: 27049344
[TBL] [Abstract][Full Text] [Related]
31. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
Cestac P; Sarrabayrouse G; Médale-Giamarchi C; Rochaix P; Balaguer P; Favre G; Faye JC; Doisneau-Sixou S
Breast Cancer Res; 2005; 7(1):R60-70. PubMed ID: 15642170
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands.
Stope MB; Popp SL; Knabbe C; Buck MB
Breast Cancer Res Treat; 2010 Apr; 120(2):357-67. PubMed ID: 19370415
[TBL] [Abstract][Full Text] [Related]
33. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma].
Shen Z; Wu Q; Yue L; Li HC; Shen ZZ; Shao ZM
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):15-8. PubMed ID: 15808068
[TBL] [Abstract][Full Text] [Related]
34. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen.
Zhang M; Yan JD; Zhang L; Wang Q; Lü SJ; Zhang J; Zhu TH
Chin Med J (Engl); 2005 Oct; 118(19):1629-36. PubMed ID: 16232348
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
[TBL] [Abstract][Full Text] [Related]
36. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator.
Liu X; An BH; Kim MJ; Park JH; Kang YS; Chang M
Biochem Biophys Res Commun; 2014 Sep; 452(3):840-4. PubMed ID: 25218501
[TBL] [Abstract][Full Text] [Related]
37. The Aryl Hydrocarbon Receptor Ligand 6-Formylindolo(3,2-b)carbazole Promotes Estrogen Receptor Alpha and c-Fos Protein Degradation and Inhibits MCF-7 Cell Proliferation and Migration.
Cano-Sánchez J; Murillo-González FE; de Jesús-Aguilar J; Cabañas-Cortés MA; Tirado-Garibay AC; Elizondo G
Pharmacology; 2023; 108(2):157-165. PubMed ID: 36657432
[TBL] [Abstract][Full Text] [Related]
38. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.
Grisouard J; Medunjanin S; Hermani A; Shukla A; Mayer D
Mol Endocrinol; 2007 Oct; 21(10):2427-39. PubMed ID: 17609434
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells.
Zhang Y; Zhou G; Wang H; Zhang X; Wei F; Cai Y; Yin D
Oncology; 2006; 71(5-6):446-55. PubMed ID: 17878748
[TBL] [Abstract][Full Text] [Related]
40. ERα/LKB1 complex upregulates E-cadherin expression and stimulates breast cancer growth and progression upon adiponectin exposure.
Naimo GD; Forestiero M; Paolì A; Malivindi R; Gelsomino L; Győrffy B; Leonetti AE; Giordano F; Panza S; Conforti FL; Ruffo P; Panno ML; Mauro L; Andò S
Int J Cancer; 2023 Sep; 153(6):1257-1272. PubMed ID: 37323038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
